Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-arginine for prevention of type 2 diabetes in metabolic syndrome
2005-004639-24Phase 3Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Oct 2005
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of arginine in cardiometabolic risk (CMR) and type 2 diabetes mellitus (T2DM), sponsored by IRCCS Ospedale San Raffaele. Started Oct 2005; status: completed.
02
Drugs
arginine
03
Conditions
cardiometabolic risk (CMR)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2005-004639-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004639-24.